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  ABSTRACT 
  Background      There is strong evidence suggesting 
that juvenile idiopathic arthritis (JIA) shares many 
susceptibility loci with other autoimmune diseases.   
  Objective      To investigate variants robustly associated 
with type 1 diabetes (T1D) or coeliac disease (CD) for 
association with JIA.   
  Methods    Sixteen  single-nucleotide  polymorphisms 
(SNPs) already identiﬁ  ed as susceptibility loci for T1D/
CD were selected for genotyping in patients with JIA 
(n=1054) and healthy controls (n=3129). Genotype and 
allele frequencies were compared using the Cochrane–
Armitage trend test implemented in PLINK.   
  Results      One SNP in the   LPP   gene, rs1464510, showed 
signiﬁ  cant association with JIA (p  trend =0.002,  OR=1.18, 
95% CI 1.06 to 1.30). A second SNP, rs653178 in   ATXN2,  
also showed nominal evidence for association with 
JIA (p  trend  =0.02, OR=1.13, 95% CI 1.02 to 1.25). The 
SNP, rs17810546, in   IL12A   showed subtype-speciﬁ  c 
association with enthesitis-related arthritis (ERA) subtype 
(p  trend  =0.005, OR=1.88, 95% CI 1.2 to 2.94).   
  Conclusions      Evidence for a novel JIA susceptibility 
locus,   LPP  , is presented. Association at the   SH2B3/
ATXN2   locus, previously reported to be associated 
with JIA in a US series, also supports this region as 
contributing to JIA susceptibility. In addition, a subtype-
speciﬁ  c association of   IL12A   with ERA is identiﬁ  ed. All 
ﬁ  ndings will require validation in independent JIA cohorts.           
  INTRODUCTION 
  In the past few years huge advances have been 
made in the understanding of the genes contribut-
ing to autoimmune disease susceptibility. It is also 
becoming clear that, despite the apparent clinical 
and phenotypic differences of the autoimmune dis-
eases, they share a number of genetic risk factors.    1    
Of note, the genetic overlap between type 1 dia-
betes (T1D), coeliac disease (CD) and rheumatoid 
arthritis (RA)    2        3    (Eyre   et al  , submitted). 
  Juvenile idiopathic arthritis (JIA) is the most 
common chronic rheumatic disease of childhood. It 
is deﬁ  ned as chronic inﬂ  ammation of the synovial 
joints, with unknown aetiology, that starts before 
the age of 16 and persists for at least 6 weeks. 
Familial clustering of other autoimmune diseases in 
JIA families is well established, with an increased 
prevalence of autoimmunity in ﬁ  rst- and second-
degree relatives of patients.    4    
  There is already strong evidence suggesting that 
JIA shares many susceptibility loci with other auto-
immune diseases such as RA, T1D and multiple 
sclerosis.    5        6    Therefore, the aim of this study was 
to test single-nucleotide polymorphisms (SNPs) 
robustly associated with T1D or CD in a large 
cohort of patients with JIA and controls to investi-
gate the overlap between these diseases.   
  METHODS 
  Subjects 
  DNA was available for 1054 UK Caucasian 
patients with JIA (332 men, 715 women)   as previ-
ously described.    6    JIA cases were classiﬁ  ed accord-
ing to the International League of Associations for 
Rheumatology (ILAR) criteria    7    (online supplemen-
tary table 1). 
  Three thousand one hundred and twenty-nine 
healthy UK Caucasian control DNA samples were 
available as described previously.    8    All individu-
als were recruited with ethical approval and pro-
vided informed consent (North-West Multi-Centre 
Research Ethics Committee (MREC 99/8/84) and 
the University of Manchester Committee on the 
Ethics of Research on Human Beings).   
  SNP  selection 
  SNPs that showed robust evidence for association 
(p<5×10  −7  ) with T1D and/or CD    2    and had not been 
investigated previously were identiﬁ  ed. In total 16 
SNPs were selected for genotyping.   
  Genotyping 
  All SNPs were genotyped, in UK JIA cases and 
controls, using the Sequenom iPlex MassARRAY 
platform according to manufacturers instructions 
(Sequenom, San Diego, California, USA, http://
www.sequenom.com, accessed 9 July 2010). A 
90% sample quality control rate and 90% SNP 
genotyping success rate was imposed on the 
analysis.   
  Statistical  analysis 
  Power calculations were performed using 
QUANTO based on the effect sizes reported 
in previous studies of these SNPs in other auto-
immune diseases. Calculations assumed a log-
  additive model and an α value corrected for the 
number of SNPs analysed. Genotype and allele 
frequencies were compared between cases with 
JIA and controls using PLINK.    9    Comparisons were 
expressed as ORs and their 95% CIs as well as 
the Cochrane–Armitage test for trend. JIA is a 
phenotypically heterogeneous disease and can be 
▶   Additional  data 
(supplementary table) are 
published online only. To view 
these ﬁ  les please visit the 
journal online (http://ard.bmj.
com). 
  1  Arthritis Research UK 
Epidemiology Unit, The 
University of Manchester, 
Manchester, UK 
  2  Haywood Hospital, University 
Hospital of North Staffordshire, 
Stoke on Trent, Staffordshire, 
ST4 7LN. 
    Correspondence  to   
Dr Anne Hinks, Arthritis 
Research UK Epidemiology 
Unit, Manchester Academic 
Health Science Centre, Stopford 
Building, The University of 
Manchester, Manchester M13 
9PT, UK; 
anne.hinks@manchester.ac.uk                                
        Investigation  of  type  1  diabetes  and  coeliac  disease 
susceptibility loci for association with juvenile 
idiopathic arthritis   
    Anne    Hinks,   1       Paul    Martin,   1       Edward    Flynn,   1       Steve    Eyre,   1       Jon    Packham,   2       Anne    Barton,   1  ;  
    Childhood Arthritis Prospective Study (CAPS), UKRAG Consortium, BSPAR study group,         
   Jane    Worthington,   1       Wendy    Thomson,   1   
19_annrheumdis126938.indd   2169 19_annrheumdis126938.indd   2169 10/29/2010   7:01:44 AM 10/29/2010   7:01:44 AMConcise report
Ann Rheum Dis 2010;69:2169–2172. doi:10.1136/ard.2009.126938 2170
classiﬁ  ed into more clinically homogeneous diseases using the 
ILAR classiﬁ  cation criteria.    7    We examined whether there was 
evidence of a difference in allele frequencies between the seven 
ILAR subtypes. Differences between subtypes were assessed 
using χ    2    tests on the 7×2 tables. Only if a signiﬁ  cant difference 
was detected was stratiﬁ  cation analysis by ILAR subtype per-
formed and ORs and 95% CIs calculated for the subtypes.     
  RESULTS 
  Genotype counts for all SNPs were in Hardy–Weinberg equilib-
rium (p>0.05) in the control cohort. Three SNPs (rs12708716, 
rs45450798 and rs229541) failed SNP quality control thresholds 
and were excluded from further analysis, leaving 13 SNPs for 
analysis. A Bonferroni correction of 13 was applied to correct 
for the number of loci studied, resulting in a p value threshold of 
0.004 for claims of signiﬁ  cance (  table 1  ). 
  One SNP in the   LPP   gene associated with CD, rs1464510, 
showed signiﬁ  cant association with JIA at the corrected thresh-
old (p  trend  =0.002, OR=1.18, 95% CI 1.06 to 1.30) (  table 1  ). A 
second SNP, rs653178, in the   ATXN2   gene associated with CD, 
was nominally associated with JIA (p  trend  =0.02, OR=1.13, 95% 
CI 1.02 to 1.25) but this was not statistically signiﬁ  cant after cor-
rection for multiple testing (p  trend  _  corrected  =0.26). 
  All SNPs were examined for differences in allele frequencies 
across the ILAR subtypes. The SNP, rs17810546, in   IL12A   associ-
ated with CD, showed a signiﬁ  cant allele frequency difference 
(p=0.03) between the subtypes and therefore this SNP was re-
analysed stratifying by ILAR subtype. The enthesitis-related 
arthritis (ERA) subtype showed strong association with   IL12A   
SNP (p  trend  =0.005, OR=1.88, 95% CI 1.2 to 2.94). There was no 
evidence for association with any other subtype.   
  DISCUSSION 
  The emerging overlap of autoimmune disease susceptibility 
loci makes many of the newly discovered T1D and CD loci 
appealing candidates for investigation as possible JIA suscep-
tibility loci. There is already some evidence for the overlap of 
JIA and T1D susceptibility loci, with conﬁ  rmed association of 
genes such as the major histocompatibility complex,   PTPN22  , 
  IL2RA  ,   IL2/21   region and   CCR5   with both diseases.    5        10   –    12    
  By investigating conﬁ  rmed CD and T1D loci in JIA we have 
identiﬁ  ed a novel locus conferring susceptibility to JIA. This SNP 
lies within the Lim domain containing preferred translocation 
partner in lipoma (  LPP  ) gene. SNPs in   LPP   show validated asso-
ciation with CD.    13        14    Interestingly, the rs1464510 SNP does not 
appear to be associated with T1D    2    and studies in RA show con-
ﬂ  icting results: in one large UK population study, no association 
was detected (p  trend  =0.82, OR=1.01, 95% CI 0.94 to 1.08) (Eyre 
  et al  , submitted) while in a Dutch population, modest evidence 
for association was reported (p=0.012, OR=1.14, 95% CI 1.03 
to 1.26).    3    
    LPP   has a number of known functions; it is important in cell 
migration, cell adhesion and acts as a versatile scaffolding and 
adaptor protein.    15    Recently,   LPP   was identiﬁ  ed as a substrate 
of the protein-tyrosine phosphatase 1B, a negative regulator of 
multiple signalling pathways downstream of receptor tyrosine 
kinases and functionally linked to Ras signalling.    16    Further work 
will be required to determine which of the multiple potential 
pathways with which the protein interacts is affected by the 
variants that predispose to autoimmune disease. 
  We also found weak evidence for association of a SNP, 
rs653178, in the   SH2B3/ATXN2   gene region with JIA, though it 
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